Alkeon Capital Management
GILD icon

Alkeon Capital Management’s Gilead Sciences GILD Stock Holding History

Alkeon Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-951,010
Closed -$101M – 64
2014
Q3 		$101M Sell
951,010
-750,000
-44% -$73.4M 2.01% 19
2014
Q2 		$141M Buy
1,701,010
+216,010
+15% +$16.8M 2.58% 15
2014
Q1 		$105M Sell
1,485,000
-500,000
-25% -$39.2M 1.77% 23
2013
Q4 		$149M Buy
1,985,000
+715,000
+56% +$49.8M 2.51% 14
2013
Q3 		$79.8M Buy
1,270,000
+220,000
+21% +$13.1M 1.56% 29
2013
Q2 		$53.8M Buy
+1,050,000
New +$54.7M 1.21% 34

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alkeon Capital Management's GILD Position: Q4 2014 in Review

Alkeon Capital Management sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 951,010 shares — an estimated $101M sold.

Alkeon Capital Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $149M in Q4 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Alkeon Capital Management reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Alkeon Capital Management sold 951,010 Gilead Sciences shares in Q4 2014, an estimated $101M.
  • Alkeon Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Alkeon Capital Management's Gilead Sciences position peaked at $149M in Q4 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Alkeon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.